View Author
cancer screening breast mortality women model breast cancer mortality breast cancer treatment result mammography difference strategy adjuvant reduction incidence tumor health disparity mammography screening adjuvant treatment population center adjuvant therapy women 25 years therapy bene fits trial research effect stage breast cancer incidence state biomarker department american group article spectrum history modeling miscan-fadia study cancer research trend death distribution association survival factor mortality disparity monogr mortality reduction november mandelblatt epidemiol onlinefirst surveillance university feuer ej number mammogram parameter age 40 years breast cancer trends services task force table ficient downloaded breast cancer screening breast cancer stage january screening strategy ravesteyn screening strategies copyright impact age 40 stage distribution interval
3 Most Recent Publications
|
Modeling the impact of population screening on breast cancer mortality in the United States
(Article)
Mandelblatt, J.S. Cronin, K.A. Zelen, M. Feuer, E.J. Berry, D.A. Chang, Y. Koning, H.J. de Lee, S.J. Plevritis, S.K. Schechter, C.B. Stout, N.K. Ravesteyn, N.T. van |
2011-10-01
|
|
Racial disparities in breast cancer mortality - Response
(Article)
Ravesteyn, N.T. van Schechter, C.B. Near, A.M. Heijnsdijk, E.A.M. Stoto, M.A. Draisma, G. Koning, H.J. de Mandelblatt, J.S. |
2011-05-01
|
|
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States
(Article)
Ravesteyn, N.T. van Schechter, C.B. Near, A.M. Heijnsdijk, E.A.M. Stoto, M.A. Draisma, G. Koning, H.J. de Mandelblatt, J.S. |
2011-01-01
|